XML 55 R37.htm IDEA: XBRL DOCUMENT
v3.25.2

Earnings Per Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Earnings Per Share [Abstract] |
Schedule of Weighted Average Number of Shares | The following table reconciles the weighted average shares outstanding for the basic earnings per share calculation to the weighted average shares outstanding for the diluted earnings per share calculation:
| Three Months Ended June 30, |  | Six Months Ended June 30,
(in thousands) | 2025 |  | 2024 |  | 2025 |  | 2024
Numerator: |  |  |  |  |  |  |
Net income (loss) | $ | 47,939 |  |  | $ | (46,851) |  |  | $ | 90,994 |  |  | $ | 9,389 |
Denominator: |  |  |  |  |  |  |
Weighted average Common Shares outstanding – basic | 182,468 |  |  | 189,680 |  |  | 183,071 |  |  | 189,909 |
Dilutive effect of outstanding securities: |  |  |  |  |  |  |
RSAs | 20 |  |  | — |  |  | 21 |  |  | 19 |
Time-based RSUs | 11 |  |  | — |  |  | 50 |  |  | 186 |
Performance-based RSUs | 412 |  |  | — |  |  | 556 |  |  | 1,354 |
Stock options | 528 |  |  | — |  |  | 669 |  |  | 942 |
Weighted average Common Shares outstanding – dilutive | 183,439 |  |  | 189,680 |  |  | 184,367 |  |  | 192,410 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following potential common shares were excluded from the computation of dilutive EPS because their effect would have been anti-dilutive:
| Three Months Ended June 30, |  | Six Months Ended June 30,
(in thousands) | 2025 |  | 2024 |  | 2025 |  | 2024
RSAs | — |  |  | 36 |  |  | — |  |  | — |
Time-based RSUs | 634 |  |  | 656 |  |  | 601 |  |  | 342 |
Performance-based RSUs | 968 |  |  | 1,872 |  |  | 989 |  |  | 661 |
Stock Options | — |  |  | 1,356 |  |  | — |  |  | — |
Total anti-dilutive shares | 1,602 |  |  | 3,920 |  |  | 1,590 |  |  | 1,003 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration